SCHEMBL9729950

SCHEMBL9729950

CC(C)n1cc(-c2ccc(F)cc2)nn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.46
PTGS1 P23219 1/20 0.46
CYP19A1 P11511 1/20 0.45
CA2 P00918 3/20 0.42
CA1 P00915 1/20 0.42
CA5A P35218 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
MAPK14 Q16539 2/20 0.42
CHRNB2 P17787 3/20 0.41
CHRNB4 P30926 3/20 0.41
CHRNA3 P32297 3/20 0.41
CHRNA7 P36544 3/20 0.41
CHRNA4 P43681 3/20 0.41
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A3 P47895 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11965518 0.84 FLT3 (0.46) PTGS2PTGS1CYP19A1CA2CA1
SCHEMBL12377290 0.82 CYP19A1 (0.62) PTGS2PTGS1CYP19A1CA2CA1
SCHEMBL12377326 0.82 PTGS2 (0.46) PTGS2PTGS1CYP19A1CA2GAA
SCHEMBL9963176 0.81 CYP19A1 (0.66) PTGS2PTGS1CYP19A1CA2CA1
SCHEMBL12377265 0.81 PTGS2 (0.49) PTGS2CYP19A1MGAMGAASI
SCHEMBL22050888 0.80 CHRNB2 (0.46) CYP19A1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL16406113 0.79 CYP19A1 (0.42) CYP19A1CA2CA1CA5ACA5B
SCHEMBL21286180 0.79 CYP19A1 (0.42) CYP19A1RAB9A
SCHEMBL19449444 0.79 MEN1 (0.51) PTGS2PTGS1CA2CA1CA5A
SCHEMBL23381117 0.79 CYP19A1 (0.43) CYP19A1CA2CA9LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222767-A1 CD33 LIGANDS SUITABLE FOR INCORPORATION INTO CARRIERS GLYCOMIMETICS, INC. (US) 2021-11-04 WO disclosed
US-5081136-A 1,2,3-TRIAZOLE COMPOUNDS ACTIVE AS INHIBITORS OF THE ENZYME HMG-COA REDUCTASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ZAMBON GROUP S.P.A. (IT) 1992-01-14 US disclosed
EP-0433842-A2 1,2,3-Triazole derivatives active as inhibitors of the enzyme HMG-COA reductase and pharmaceutical compositions containing them ZAMBON GROUP S.p.A. (IT) 1991-06-26 EP disclosed